| PERIOD ENDING | 31-Dec-08 | 31-Dec-07 | 31-Dec-06 | | Total Revenue | 10,561,100 | 9,003,300 | 6,487,500 | | Cost of Revenue | 4,112,400 | 3,740,500 | 2,781,900 | | | Gross Profit | 6,448,700 | 5,262,800 | 3,705,600 | | | Operating Expenses | | Research Development |
-
|
-
|
-
| | Selling General and Administrative | 2,069,100 | 1,888,400 | 1,439,400 | | Non Recurring | 158,500 | 214,500 | 29,200 | | Others | 2,857,700 | 2,493,100 | 1,884,700 | | | | Total Operating Expenses |
-
|
-
|
-
| | | | Operating Income or Loss | 1,363,400 | 666,800 | 352,300 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (383,000) | 331,300 | 137,900 | | Earnings Before Interest And Taxes | 980,400 | 1,031,800 | 503,200 | | Interest Expense | 1,147,400 | 982,100 | 673,400 | | Income Before Tax | (167,000) | 49,700 | (170,200) | | Income Tax Expense | 434,800 | 233,100 | (7,900) | | Minority Interest | (187,100) | (239,200) | (171,700) | | | | Net Income From Continuing Ops | (788,900) | (422,600) | (334,000) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
| 1,040,200 | | Extraordinary Items |
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
| | Other Items |
-
|
-
|
-
| | | | Net Income | (788,900) | (422,600) | 706,200 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($788,900) | ($422,600) | $706,200 |
|
0.29% Nasdaq 
Income Statement
